
Garcia lab
@pggarcialab
Stem cells and genome stability, DNA damage, cancer, adult stem cells, iPSC, leukaemia, MDS, MYBL2
ID: 1299655040668520448
http://birmingham.ac.uk/paloma-garcia 29-08-2020 10:28:35
737 Tweet
332 Followers
191 Following

#singlecell epigenomic technologies are redefining our understanding of cancer evolution. Now, Marthe LAISNE, Mathieu Lupien & Céline Vallot explain how epigenomic heterogeneity drives tumor cell state diversity through reprogramming and selection. go.nature.com/3NyflWN



Excited to share this collaborative effort with Dian Yang & Matt Jones, combining Cas9 evolving lineage tracing and spatial techniques to study lung cancer evolution. Great supports from Fei Chen Lab, Jonathan Weissman's Lab & Yosef Lab. biorxiv.org/content/10.110…


🚨 Great alternatives to BioRender are now available!! 📢 NIAID News offers a collection of public figures and icons for everyone to use. Check it out at bioart.niaid.nih.gov







Check out this new iSAM-Cas9 hESC line developed in the lab in colaboration with Antonella Fidanza and Ana Sevilla at Universitat de Barcelona! Nice tool to multiplex gente activation. frontiersin.org/journals/cell-…

In 2025 the University will celebrate its 125th anniversary. One of the ways it’s celebrating is by making a major investment in the Birmingham research community with the appointment of 125 Anniversary Fellows and Chairs. Uni of Birmingham Find out more: fellowsandchairs.birmingham.ac.uk


This week in The EMBO Journal! 👀 The authors reveal that early embryos undergo the transition from #totipotency to pluripotency by employing a relay between histone methyltransferases MLL2 and SETD1A/B to deposit H3K4me3. 📚 Give it a read: bit.ly/4gonk5e


Delighted to announce that our paper showing that PRMT5 drives chemo resistance in breast cancer stem cells by regulating splicing of DDR genes is published!! Big shout out to Kelly and Matthew. Funded by Cancer Research UK, Breast Cancer Now search.app/Z4ZwpAfpfUojFX…

PRMT5 regulates chemoresistance in #BreastCancer stem cells by controlling the splicing of DNA damage response genes. Combining PRMT5 inhibitors with DNA damaging chemo kills BCSCs. New approaches to target drug resistant BCSCs from Davies Lab - CH3 🔎nature.com/articles/s4138…



**NEW Doctoral Training Programme just launched!!** This exciting programme on Microbial Genomics for Health Protection is joint between IMIBirmingham Uni of Birmingham and UKHSA UK Health Security Agency 9 brilliant projects available!! birmingham.ac.uk/research/centr…